These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8016096)

  • 1. Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides.
    Perez JR; Li Y; Stein CA; Majumder S; van Oorschot A; Narayanan R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5957-61. PubMed ID: 8016096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid induction of Jak2 and Sp1 in T cells by phosphorothioate oligonucleotides.
    Too CK
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):87-94. PubMed ID: 9593046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence context of antisense RelA/NF-kappa B phosphorothioates determines specificity.
    Maltese JY; Sharma HW; Vassilev L; Narayanan R
    Nucleic Acids Res; 1995 Apr; 23(7):1146-51. PubMed ID: 7739892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
    J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An EGFR antisense oligodeoxynucleotides and its phosphorothioate analogue inhibit the growth of human hepatocarcinoma BEL-7404 cells].
    Lin JQ; Xu ZS; Zhang HY; Yang ZW; Xu YH
    Shi Yan Sheng Wu Xue Bao; 1995 Sep; 28(3):241-6. PubMed ID: 8571707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor decoy approach to decipher the role of NF-kappa B in oncogenesis.
    Sharma HW; Perez JR; Higgins-Sochaski K; Hsiao R; Narayanan R
    Anticancer Res; 1996; 16(1):61-9. PubMed ID: 8615671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
    Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH
    Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase as a potential molecular target to study G-quartet phosphorothioates.
    Sharma HW; Hsiao R; Narayanan R
    Antisense Nucleic Acid Drug Dev; 1996; 6(1):3-7. PubMed ID: 8783790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
    Wu AG; Joshi SS; Chan WC; Iversen PL; Jackson JD; Kessinger A; Pirruccello SJ; Sanger WG; Sharp JG; Verbik DJ
    Leuk Lymphoma; 1995 Dec; 20(1-2):67-76. PubMed ID: 8750625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of phosphorothioate-modified oligodeoxynucleotides to inhibit NF-kappaB expression and lymphocyte function.
    Khaled AR; Butfiloski EJ; Sobel ES; Schiffenbauer J
    Clin Immunol Immunopathol; 1998 Feb; 86(2):170-9. PubMed ID: 9473379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the p50 (NKkappaB1) subunit of NF-kappaB by phosphorothioate-modified antisense oligodeoxynucleotides reduces NF-kappaB expression and immunoglobulin synthesis in murine B cells.
    Khaled AR; Soares LS; Butfiloski EJ; Stekman I; Sobel ES; Schiffenbauer J
    Clin Immunol Immunopathol; 1997 Jun; 83(3):254-63. PubMed ID: 9175914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a phosphorothioate oligodeoxynucleotide MCP-1 on NF-kappaB, AP-1, SP1 and NF-kappaB, and AP-1 subunit composition in human pulmonary endothelial cells.
    Maus U; Seeger W; Lohmeyer J
    Antisense Nucleic Acid Drug Dev; 2001 Feb; 11(1):59-64. PubMed ID: 11258622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.
    Reuning U; Wilhelm O; Nishiguchi T; Guerrini L; Blasi F; Graeff H; Schmitt M
    Nucleic Acids Res; 1995 Oct; 23(19):3887-93. PubMed ID: 7479032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
    Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
    Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
    Del Bufalo D; Cucco C; Leonetti C; Citro G; D'Agnano I; Benassi M; Geiser T; Zon G; Calabretta B; Zupi G
    Br J Cancer; 1996 Aug; 74(3):387-93. PubMed ID: 8695353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorothioate oligonucleotides cause degradation of secretory but not intracellular serglycin proteoglycan core protein in a sequence-independent manner in human megakaryocytic tumor cells.
    Schick BP; Eras JL; Mintz PS
    Antisense Res Dev; 1995; 5(1):59-65. PubMed ID: 7613073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression.
    Higgins KA; Perez JR; Coleman TA; Dorshkind K; McComas WA; Sarmiento UM; Rosen CA; Narayanan R
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9901-5. PubMed ID: 8234333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-erbB-2 anti-sense phosphorothioate oligodeoxynucleotides inhibit growth and serum-induced cell spreading of P185c-erbB-2-overexpressing ovarian carcinoma cells.
    Wiechen K; Dietel M
    Int J Cancer; 1995 Nov; 63(4):604-8. PubMed ID: 7591273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides.
    Lorenz P; Misteli T; Baker BF; Bennett CF; Spector DL
    Nucleic Acids Res; 2000 Jan; 28(2):582-92. PubMed ID: 10606658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.